Table 1 VAM biomarker values in three different tumor areas and peritumoral edema.

From: Vascular Hysteresis Loops and Vascular Architecture Mapping in Patients with Glioblastoma treated with Antiangiogenic Therapy

 

Ex.

Tumor response

Tumor non-resp.

Tumor progress

Edema response

Edema non-resp.

Edema progress

cNAB

(N = 13)a

(N = 9)a

(N = 8)a

(N = 13)a

(N = 9)a

(N = 8)a

(N = 13)a

MTI

bl

−82.2 ± 60.4

−147.8 ± 80.2

−6.0 ± 5.8

0.3 ± 1.0

−0.4 ± 1.1

−0.5 ± 1.2

0.0 ± 0.7

[s−5/2]

fu

−4.2 ± 6.4*

−196.0 ± 78.7*

−67.1 ± 66.1*

−1.4 ± 2.7

−0.1 ± 2.6

0.4 ± 2.9

0.2 ± 0.6

NU

bl

498 ± 132

484 ± 171

277 ± 125

101 ± 52

120 ± 43

151 ± 53

180 ± 37

[mm−2]

fu

212 ± 103*

656 ± 101*

511 ± 170*

173 ± 94*

162 ± 43*

129 ± 48

164 ± 28

RU

bl

102 ± 45

86 ± 48

42 ± 19

83 ± 44

61 ± 18

43 ± 19

29 ± 7

[µm]

fu

65 ± 36*

124 ± 39*

84 ± 53*

54 ± 27

77 ± 33

91 ± 28*

28 ± 6

Curv

bl

−7 ± 6

−8 ± 11

−22 ± 22

−197 ± 97

−140 ± 55

−33 ± 24

−15 ± 6

 

fu

−85 ± 103*

−30 ± 79

−11 ± 13

−49 ± 7*

−118 ± 82

−179 ± 76*

−17 ± 8

  1. Values are mean values ± standard deviation.
  2. aIn parentheses: number of patients.
  3. *Values marked with an asterisks are significant (P < 0.05) different to the value at the baseline examination.
  4. Note: MTI = microvessel type indicator; NU = microvessel density; RU = microvessel radius; Curv = curvature of the long-axis of the VHL; Exam. = examination; bl = baseline; fu = 3-month follow-up, cNAB = contralateral normal appearing brain.